Close
Patheon
Solubilization Technology
Product Development
Author: Sanjay Konagurthu, Ph.D.
Friday, October 09, 2015

The proportion of poorly soluble drug compounds in the development pipeline is on the rise, with 70% to 90% of current pipeline drugs falling in the two low-solubility classes of the Biopharmaceutical Classification System. With the emergence of new techniques to improve solubility, low solubility compounds are more likely to advance to the clinic. But the large spectrum of available technologies can make it challenging for the formulation scientist to proceed in an informed and rational manner. At this point, the following questions should be addressed: what formulation technologies are available; what features of the drug might suggest one technology over another; are the technologies scalable and what are the costs; and what is the approach to making a rational technology selection? The following presents a brief overview of the various solubilization technologies, and a high level strategy to aid in the selection of an appropriate formulation technology.

 

Please complete the short form below to download this whitepaper.

Looking for Solutions?

We can help.